Efficacy of Oncolytic Herpes Simplex Virus T-VEC Combined with BET Inhibitors as an Innovative Therapy Approach for NUT Carcinoma

por Ohnesorge, Paul V., Berchtold, Susanne, Beil, Julia, Haas, Simone A., Smirnow, Irina, Schenk, Andrea, French, Christopher A., Luong, Nhi M., Huang, Yeying, Fehrenbacher, Birgit, Schaller, Martin, Lauer, Ulrich M.
Publicado 2022

The BRD4–NUT Fusion Alone Drives Malignant Transformation of NUT Carcinoma

por Durall, R. Taylor, Huang, Julianna, Wojenski, Luke, Huang, Yeying, Gokhale, Prafulla C., Leeper, Brittaney A., Nash, Joshua O., Ballester, Pedro L., Davidson, Scott, Shlien, Adam, Sotirakis, Emmanuel, Bertaux, Fabien, Dubus, Vincent, Luo, Jia, Wu, Catherine J., Keskin, Derin B., Eagen, Kyle P., Shapiro, Geoffrey I., French, Christopher A.
Publicado 2023

EZH2 synergizes with BRD4-NUT to drive NUT carcinoma growth through silencing of key tumor suppressor genes

por Huang, Yeying, Durall, R. Taylor, Luong, Nhi M., Hertzler, Hans J., Huang, Julianna, Gokhale, Prafulla C., Leeper, Brittaney A., Persky, Nicole S., Root, David E., Anekal, Praju V., Montero Llopis, Paula D.L.M., David, Clement N., Kutok, Jeffery L., Raimondi, Alejandra, Saluja, Karan, Luo, Jia, Zahnow, Cynthia A., Adane, Biniam, Stegmaier, Kimberly, Hawkins, Catherine E., Ponne, Christopher, Le, Quan, Shapiro, Geoffrey I., Lemieux, Madeleine E., Eagen, Kyle P., French, Christopher A.
Publicado 2023